254
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Relationship between serum alkaline phosphatase level, C-reactive protein and leukocyte counts in adults aged 60 years or older

, &
Pages 233-237 | Received 04 Dec 2018, Accepted 18 Feb 2019, Published online: 19 Mar 2019

References

  • Weiss MJ, Henthorn PS, Lafferty MA, et al. Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase. Proc Natl Acad Sci USA. 1986;83:7182–7186.
  • Stigbrand T. Present status and future trends of human alkaline phosphatases. Prog Clin Biol Res. 1984;166:3–14.
  • Epstein E, Kiechle FL, Artiss JD, et al. The clinical use of alkaline phosphatase enzymes. Clin Lab Med. 1986;6:491–505.
  • Tonelli M, Curhan G, Pfeffer M, et al. Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation. 2009;120:1784–1792.
  • Shimizu Y, Imano H, Ohira T, et al. CIRCS Investigators. Alkaline phosphatase and risk of stroke among Japanese: the Circulatory Risk in Communities Study (CIRCS). J Stroke Cerebrovasc Dis. 2013;22:1046–1055.
  • Krishnamurthy VR, Baird BC, Wei G, et al. Associations of serum alkaline phosphatase with metabolic syndrome and mortality. Am J Med. 2011;124:566.e1–567.
  • Beddhu S, Ma X, Baird B, et al. Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:1805–1810.
  • Chen SC, Tsai SP, Jhao JY, et al. Liver fat, hepatic enzymes, alkaline phosphatase and the risk of incident type 2 diabetes: a prospective study of 132,377 adults. Sci Rep. 2017;7:4649.
  • Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695.
  • Wu Z, Huang Z, Jin W, et al. Peripheral inflammatory biomarkers for myocardial infarction risk: a prospective community-based study. Clin Chem. 2017;63:663–672.
  • Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327–334.
  • Fox ER, Benjamin EJ, Sarpong DF, et al. The relation of C-reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study. BMC Nephrol. 2010;11:1.
  • Zhou YJ, Zou H, Zheng JN, et al. Serum alkaline phosphatase, a risk factor for non-alcoholic fatty liver, but only for women in their 30s and 40s: evidence from a large cohort study. Expert Rev Gastroenterol Hepatol. 2017;11:269–276.
  • Kim MK, Baek KH, Kang MI, et al. Serum alkaline phosphatase, body composition, and risk of metabolic syndrome in middle-aged Korean. Endocr J. 2013;60:321–328.
  • Wannamethee SG, Sattar N, Papcosta O, et al. Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men. Arterioscler Thromb Vasc Biol. 2013;33:1070–1076.
  • Kunutsor SK, Apekey TA, Khan H. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies. Atherosclerosis. 2014;236:7–17.
  • Ryu WS, Lee SH, Kim CK, et al. High serum alkaline phosphatase in relation to cerebral small vessel disease. Atherosclerosis. 2014;232:313–318.
  • Damera S, Raphael KL, Baird BC, et al. Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease. Kidney Int. 2011;79:228–233.
  • Filipowicz R, Greene T, Wei G, et al. Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality. Clin J Am Soc Nephrol. 2013;8:26–32.
  • Kerner A, Avizohar O, Sella R, et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. ATVB. 2005;25:193–197.
  • Deepika G, Veeraiah S, Naveed N, et al. Serum alkaline phosphatase and high sensitivity C-reactive protein in type II diabetes mellitus: a risk of cardio vascular disease in South Indian population. Int J Res Med Sci. 2016;4:1107–1114.
  • Cheung BM, Ong KL, Cheung RV, et al. Association between plasma alkaline phosphatase and C-reactive protein in Hong Kong Chinese. Clin Chem Lab Med. 2008;46:523–527.
  • Webber M, Krishnan A, Thomas NG, et al. Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005–2006. Clin Chem Lab Med. 2010;48:167–173.
  • Phillips CM, Harrington JM, Perry IJ. Relationship between dietary quality, determined by DASH score, and cardiometabolic health biomarkers: a cross-sectional analysis in adults. Clin Nutr. 2018. doi: 10.1016/j.clnu.2018.08.028 [Epub ahead of print].
  • Di Bonito P, Pacifico L, Chiesa C, et al. “CARdiometabolic risk factors in overweight and obese children in ITALY” (CARITALY) Study Group. White blood cell count may identify abnormal cardiometabolic phenotype and preclinical organ damage in overweight/obese children. Nutr Metab Cardiovasc Dis. 2016;26:502–509.
  • de Rooij SR, Nijpels G, Nilsson PM, et al. Relationship Between Insulin Sensitivity and Cardiovascular Disease (RISC) Investigators. Low-grade chronic inflammation in the relationship between insulin sensitivity and cardiovascular disease(RISC) population: associations with insulin resistance and cardiometabolic risk profile. Diabetes Care. 2009;32:1295–1301.
  • Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180–183.
  • Bonizzi G, Piette J, Schoonbroodt S, et al. Role of the protein kinase c lambda/iota isoform in nuclear factor-kappa B activation by interleukin1beta or tumor necrosis factor-alpha: cell type specificities. Biochem Pharmacol. 1999;57:713–720.
  • Espinosa-Diez C, Miguel V, Mennerich D, et al. Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol. 2015;6:183–197.
  • Sesti F, Tsitsilonis OE, Kotsinas A, et al. Oxidative stress-mediated biomolecular damage and inflammation in tumorigenesis. In Vivo. 2012;26:395–402.
  • Mody N, Parhami F, Sarafian TA, et al. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med. 2001;15:509–519.
  • López-Posadas R, González R, Ballester I, et al. Tissue-nonspecific alkaline phosphatase is activated in enterocytes by oxidative stress via changes in glycosylation. Inflamm Bowel Dis. 2011;17:543–556.
  • Torino C, Mattace-Raso F, van Saase JL, et al. Oxidative stress as estimated by gamma-glutamyl transferase levels amplifies the alkalinephosphatase-dependent risk for mortality in ESKD patients on dialysis. Oxid Med Cell Longev. 2016;2016:8490643.
  • Yılmaz S, Kaya E, Comakli S. Vitamin E (α tocopherol) attenuates toxicity and oxidative stress induced by aflatoxin in rats. Adv Clin Exp Med. 2017;26:907–917.
  • Ndrepepa G, Xhepa E, Braun S, et al. Alkaline phosphatase and prognosis in patients with coronary artery disease. Eur J Clin Invest. 2017;47:378–387.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.